Retrieve available abstracts of 74 articles: HTML format
Single Articles
May 2025
KLUIJVER LG, Wagenmakers MAEM, Wilson JHP, Langendonk JG, et al The Impact of Minimal Sunlight Exposure on Bone Health: Insights From a Cohort
Study in Erythropoietic Protoporphyria.
J Clin Endocrinol Metab. 2025;110:1633-1646. PubMedAbstract available
BIOLETTO F, Pusterla A, Fraire F, Sauro L, et al Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone
Density and Quality.
J Clin Endocrinol Metab. 2025;110:e2071-e2079. PubMedAbstract available
April 2025
MORELLI V, Favero V, Frigerio S, Aresta C, et al Adrenalectomy reduces the risk of vertebral fractures in patients with mild
autonomous cortisol secretion.
J Clin Endocrinol Metab. 2025 Apr 11:dgaf227. doi: 10.1210. PubMedAbstract available
ZOULAKIS M, Axelsson KF, Litsne H, Johansson L, et al Bone Marrow Adiposity Assessed by HRpQCT Is Related to Fracture Risk and Bone
Mineral Density in Older Swedish Women.
J Clin Endocrinol Metab. 2025 Apr 3:dgaf216. doi: 10.1210. PubMedAbstract available
March 2025
ZEMEL BS, Winer KK, Kelly A, Freedman DS, et al Race-Neutral Pediatric Reference Ranges for Bone Mineral Density Predict
Prospective Fractures in Childhood.
J Clin Endocrinol Metab. 2025 Mar 25:dgaf183. doi: 10.1210. PubMedAbstract available
NILSSON M, Akesson KE, Thier M, Nordenstrom E, et al Response to "Letter to the Editor from Candemir and Cakal: [24-hour Urine Calcium
Predicts Reduced Fracture Incidence and Improved Bone Mineral Density After
Surgery for Primary Hyperparathyroidism]".
J Clin Endocrinol Metab. 2025 Mar 6:dgaf127. doi: 10.1210. PubMed
CANDEMIR B, Cakal E "Letter to the Editor from Candemir and Cakal: [24-hour Urine Calcium Predicts
Reduced Fracture Incidence and Improved Bone Mineral Density After Surgery for
Primary Hyperparathyroidism]".
J Clin Endocrinol Metab. 2025 Mar 6:dgaf126. doi: 10.1210. PubMed
February 2025
UEHARA A, Mok Y, Matsushita K, Lutsey PL, et al Serum Sodium, Potassium, Magnesium, Calcium, and Phosphorus Levels and Risk of
Fracture in the Community.
J Clin Endocrinol Metab. 2025 Feb 26:dgaf120. doi: 10.1210. PubMedAbstract available
STANCAMPIANO MR, Pitea M, Maruca K, Meroni SLC, et al Bone mineral density in patients with congenital adrenal hyperplasia from
prepubertal to adult age.
J Clin Endocrinol Metab. 2025 Feb 25:dgaf123. doi: 10.1210. PubMedAbstract available
BIOLETTO F, Sibilla M, Berton AM, Prencipe N, et al Mild Hyponatremia Is Not Associated With Degradation of Trabecular Bone
Microarchitecture Despite Bone Mass Loss.
J Clin Endocrinol Metab. 2025;110:e774-e782. PubMedAbstract available
PAPADOPOULOU-MARKETOU N, Papageorgiou A, Marketos N, Tsiamyrtzis P, et al Effective Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal
Osteoporosis.
J Clin Endocrinol Metab. 2025 Feb 7:dgaf077. doi: 10.1210. PubMedAbstract available
January 2025
FERRARI S, Betah D, Feldman RG, Langdahl BL, et al Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women
With Osteoporosis and Diabetes.
J Clin Endocrinol Metab. 2025 Jan 24:dgae862. doi: 10.1210. PubMedAbstract available
EVERHART AO, Brito JP, Clarke BL, Herrin J, et al Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare
Advantage Enrollees in the United States, 2011-2022.
J Clin Endocrinol Metab. 2025 Jan 15:dgae840. doi: 10.1210. PubMedAbstract available
IMANISHI Y, Imai T, Fujii H, Aida R, et al Eldecalcitol Add-On to Risedronate Reduces Bone Loss from Aromatase Inhibitors in
Postmenopausal Breast Cancer Patients.
J Clin Endocrinol Metab. 2025 Jan 15:dgaf019. doi: 10.1210. PubMedAbstract available
December 2024
Correction to: "Cardiovascular Safety of Romosozumab vs PTH Analogues for
Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study".
J Clin Endocrinol Metab. 2024 Dec 17:dgae870. doi: 10.1210. PubMed
KONG SH, Park JY, Shin MK, Lee HJ, et al Effectiveness of Bisphosphonates in Young Adults with Fragility Fractures:
Representative Population-Based Cohort Study.
J Clin Endocrinol Metab. 2024 Dec 6:dgae850. doi: 10.1210. PubMedAbstract available
HANSEN BB, Hass Rubin K, Vind Nielsen C, Frost Nielsen M, et al Biological Heterogeneity in Susceptibility to Glucocorticoid-Induced Bone Loss:
Short- and Long-Term Hip BMD Trajectories.
J Clin Endocrinol Metab. 2024 Dec 3:dgae832. doi: 10.1210. PubMedAbstract available
November 2024
BURDEN AM, Martinez-De la Torre A, Burkard T, Immoos M, et al Increased risk of fracture among patients with iron overload: a population-based
matched cohort study.
J Clin Endocrinol Metab. 2024 Nov 18:dgae807. doi: 10.1210. PubMedAbstract available
KAWAZOE M, Kaneko K, Masuoka S, Yamada S, et al Comparison of efficacy of romosozumab with denosumab and risedronate in patients
newly initiating glucocorticoid therapy.
J Clin Endocrinol Metab. 2024 Nov 18:dgae810. doi: 10.1210. PubMedAbstract available
BLANDIN C, Collet C, Ostertag A, Funck-Brentano T, et al Genetics and bone mineral density predict the fractures in adults with
osteogenesis imperfecta: a prospective study.
J Clin Endocrinol Metab. 2024 Nov 8:dgae791. doi: 10.1210. PubMedAbstract available
WANG B, Dhaliwal R, Ewing SK, Schwartz AV, et al F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes.
J Clin Endocrinol Metab. 2024 Nov 8:dgae788. doi: 10.1210. PubMedAbstract available
October 2024
NORDSTROM P, Ballin M, Nordstrom A Associations between Balance Measures and Risk of Fractures in 70-Year-Old
Individuals: A Population-Based Cohort Study.
J Clin Endocrinol Metab. 2024 Oct 29:dgae766. doi: 10.1210. PubMedAbstract available
SHA L, Zhang L, Zhao X, Xiang R, et al Shared Genetic Architecture and Causal Relationship between Serum
25-Hydroxyvitamin D and Bone Mineral Density.
J Clin Endocrinol Metab. 2024 Oct 21:dgae738. doi: 10.1210. PubMedAbstract available
KHOSLA S The Complex Interplay of Sex Steroids and Sex Hormone-binding Globulin in
Determining Fracture Risk in Men.
J Clin Endocrinol Metab. 2024 Oct 18:dgae742. doi: 10.1210. PubMed
WANG S, Yu EW, Hivert MF, Rifas-Shiman SL, et al Associations of AMH in mid-reproductive years with bone mineral density and
turnover markers in mid-life.
J Clin Endocrinol Metab. 2024 Oct 17:dgae694. doi: 10.1210. PubMedAbstract available
CAULEY JA, Lui LY, LeBoff MS, Watts NB, et al New Challenges: Use and Interpretation of Radius Bone Mineral Density.
J Clin Endocrinol Metab. 2024 Oct 15:dgae726. doi: 10.1210. PubMedAbstract available
SUN X, Bolster MB, Leder BZ, Fan W, et al Dose-specific effects of denosumab on serum calcium levels in patients with
osteoporosis and various renal functions.
J Clin Endocrinol Metab. 2024 Oct 11:dgae721. doi: 10.1210. PubMedAbstract available
PEPE J, Colangelo L, Diacinti D, Angelozzi M, et al Association between radius axial low-frequency ultrasound velocity and bone
fragility in primary hyperparathyroidism.
J Clin Endocrinol Metab. 2024 Oct 4:dgae695. doi: 10.1210. PubMedAbstract available
September 2024
MOTLAGHZADEH Y, Wu JY Approach to Bone Health in the Patient With Breast Cancer.
J Clin Endocrinol Metab. 2024;109:e1902-e1910. PubMedAbstract available
LANGDAHL B, Chung YS, Plebanski R, Czerwinski E, et al Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal
Osteoporosis: Phase 3 Results Up to Month 12.
J Clin Endocrinol Metab. 2024 Sep 7:dgae611. doi: 10.1210. PubMedAbstract available
August 2024
WARD LM, Bakhamis S, Koujok K Approach to the Pediatric Patient with Glucocorticoid-Induced Osteoporosis.
J Clin Endocrinol Metab. 2024 Aug 10:dgae507. doi: 10.1210. PubMedAbstract available
July 2024
HARTZ MC, Johannessen FB, Harslof T, Langdahl BL, et al The Effectiveness and Safety of Romosozumab and Teriparatide in Postmenopausal
Women with Osteoporosis.
J Clin Endocrinol Metab. 2024 Jul 16:dgae484. doi: 10.1210. PubMedAbstract available
ZHOU Z, Xu H, Fu J, Wei P, et al Urolithiasis Causes Osteoporosis in Asians: Genetic Evidence from Mendelian
Randomization and Pathway Analysis.
J Clin Endocrinol Metab. 2024 Jul 8:dgae461. doi: 10.1210. PubMedAbstract available
June 2024
TSOURDI E Drug holidays with bisphosphonates in osteoporosis treatment: one size does not
fit all.
J Clin Endocrinol Metab. 2024 Jun 26:dgae438. doi: 10.1210. PubMed
May 2024
TSAI YL, Chuang YC, Cheng YY, Deng YL, et al Low Bone Mineral Density as a Predictor of Mortality and Infections in Stroke
Patients: A Hospital-based Study.
J Clin Endocrinol Metab. 2024 May 25:dgae365. doi: 10.1210. PubMedAbstract available
STOKAR J, Szalat A Response to Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of
Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score
Matched Cohort Study.
J Clin Endocrinol Metab. 2024 May 20:dgae348. doi: 10.1210. PubMed
KAWAGUCHI H Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs.
PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study'.
J Clin Endocrinol Metab. 2024 May 18:dgae347. doi: 10.1210. PubMed
April 2024
Correction to: "Increased Risk of Vertebral Fractures in Patients With Mild
Autonomous Cortisol Secretion".
J Clin Endocrinol Metab. 2024 Apr 22:dgae246. doi: 10.1210. PubMed
LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al Impact of oral bisphosphonate drug holiday on mortality following hip fracture: a
population-based cohort study.
J Clin Endocrinol Metab. 2024 Apr 17:dgae272. doi: 10.1210. PubMedAbstract available
KAMANDA-KOSSEH M, Shiau S, Agarwal S, Kondapalli A, et al Bisphosphonates Maintain BMD after Sequential Teriparatide and Denosumab in
Premenopausal Women with Idiopathic Osteoporosis.
J Clin Endocrinol Metab. 2024 Apr 12:dgae240. doi: 10.1210. PubMedAbstract available
ZHANG X, Cheung KS, Mak LY, Tan KCB, et al Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis: A Prospective
Cohort Study.
J Clin Endocrinol Metab. 2024 Apr 4:dgae223. doi: 10.1210. PubMedAbstract available
March 2024
HE D, Liu H, Zhao Y, Wei W, et al Assessing the interaction effects of mitochondrial DNA polymorphisms and
lifestyle on heel bone mineral density.
J Clin Endocrinol Metab. 2024 Mar 27:dgae195. doi: 10.1210. PubMedAbstract available
STOKAR J, Szalat A Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment:
a Propensity Score Matched Cohort Study.
J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210. PubMedAbstract available
February 2024
TRAMONTANA F, Napoli N, Litwack-Harrison S, Bauer DC, et al More rapid bone mineral density loss in older men with diabetes: The Osteoporotic
Fractures in Men (MrOS) Study.
J Clin Endocrinol Metab. 2024 Feb 26:dgae045. doi: 10.1210. PubMedAbstract available
MORI Y, Mori N Letter to the Editor From Mori and Mori: "Sequential Therapy for the Long-Term
Treatment of Postmenopausal Osteoporosis".
J Clin Endocrinol Metab. 2024 Feb 9:dgae083. doi: 10.1210. PubMed
January 2024
MINISOLA S, Cipriani C, Colangelo L, Pepe J, et al At the Intersection Between Skeletal and Hematopoietic Systems: Incorporating
Hemoglobin in FRAX(R).
J Clin Endocrinol Metab. 2024;109:e856-e857. PubMed
BAUER DC, Black DM, Dell R, Fan B, et al Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case Cohort
Study with Blinded Radiographic Review.
J Clin Endocrinol Metab. 2024 Jan 10:dgae023. doi: 10.1210. PubMedAbstract available
December 2023
STYRKARSDOTTIR U, Tragante V, Stefansdottir L, Thorleifsson G, et al Obesity variants in the GIPR gene do not associate with risk of fracture or bone
mineral density.
J Clin Endocrinol Metab. 2023 Dec 20:dgad734. doi: 10.1210. PubMedAbstract available
PRINCE RL New Data on the Increased hip Fracture Risk in Type 2 Diabetes and Its Reduction
in Those With High Physical Activity.
J Clin Endocrinol Metab. 2023 Dec 14:dgad712. doi: 10.1210. PubMed
November 2023
WANG M, Seibel MJ Approach to the Patient With Bone Fracture: Making the First Fracture the Last.
J Clin Endocrinol Metab. 2023;108:3345-3352. PubMedAbstract available
October 2023
ZHANG X, Chen X, Li S, Gao M, et al Association between advanced glycation end products and sarcopenia: The mediating
role of osteoporosis.
J Clin Endocrinol Metab. 2023 Oct 31:dgad640. doi: 10.1210. PubMedAbstract available
September 2023
FAVERO V, Eller-Vainicher C, Morelli V, Cairoli E, et al Increased risk of vertebral fractures in patients with mild autonomous cortisol
secretion.
J Clin Endocrinol Metab. 2023 Sep 21:dgad560. doi: 10.1210. PubMedAbstract available
ANAGNOSTIS P, Lampropoulou-Adamidou K, Bosdou JK, Trovas G, et al Comparative effectiveness of therapeutic interventions in pregnancy and
lactation-associated osteoporosis: a systematic review and meta-analysis.
J Clin Endocrinol Metab. 2023 Sep 14:dgad548. doi: 10.1210. PubMedAbstract available
August 2023
FLOKAS ME, Wakim P, Kollender S, Sinaii N, et al Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral
Density in Congenital Adrenal Hyperplasia.
J Clin Endocrinol Metab. 2023 Aug 29:dgad514. doi: 10.1210. PubMedAbstract available
RAMCHAND SK, Leder BZ Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis.
J Clin Endocrinol Metab. 2023 Aug 23:dgad496. doi: 10.1210. PubMedAbstract available
PHUNG K, McAdam L, Ma J, McMillan HJ, et al Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated
Males with Duchenne Muscular Dystrophy.
J Clin Endocrinol Metab. 2023 Aug 23:dgad435. doi: 10.1210. PubMedAbstract available
SZULC P, Lewis JR, Chapurlat R Accelerated bone loss in older men with severe abdominal aortic calcification -
the prospective MINOS study.
J Clin Endocrinol Metab. 2023 Aug 23:dgad459. doi: 10.1210. PubMedAbstract available
CHILOIRO S, Frara S, Gagliardi I, Bianchi A, et al Cholecalciferol use is associated with a decreased risk of incident morphometric
vertebral fractures in acromegaly.
J Clin Endocrinol Metab. 2023 Aug 22:dgad493. doi: 10.1210. PubMedAbstract available
SOTO-PEDRE E, Lin YY, Soto-Hernaez J, Newey PJ, et al Morbidity Associated With Primary Hyperparathyroidism-A Population-based Study
With a Subanalysis on Vitamin D.
J Clin Endocrinol Metab. 2023;108:e842-e849. PubMedAbstract available
LIN SY, Chen WJ, Ku CK, Chen YM, et al Treatment Persistence and Medication Switch Associated with Subsequent Fractures
after Osteoporotic Fractures.
J Clin Endocrinol Metab. 2023 Aug 1:dgad449. doi: 10.1210. PubMedAbstract available
July 2023
LABAYEN I, Cadenas-Sanchez C, Idoate F, Medrano M, et al Liver fat, bone marrow adipose tissue and bone mineral density in children with
overweight.
J Clin Endocrinol Metab. 2023 Jul 25:dgad429. doi: 10.1210. PubMedAbstract available
CAPPOLA AR, Auchus RJ, El-Hajj Fuleihan G, Handelsman DJ, et al Hormones and Aging: An Endocrine Society Scientific Statement.
J Clin Endocrinol Metab. 2023;108:1835-1874. PubMedAbstract available
TRINH A, Milat F Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children
With Cerebral Palsy: A Randomized, Controlled Trial.
J Clin Endocrinol Metab. 2023 Jul 12:dgad386. doi: 10.1210. PubMed
JAISWAL R, Johansson H, Axelsson KF, Magnusson P, et al Hemoglobin levels improve fracture risk prediction in addition to FRAX(R) clinical
risk factors and bone mineral density.
J Clin Endocrinol Metab. 2023 Jul 5:dgad399. doi: 10.1210. PubMedAbstract available
June 2023
WATTS NB, Leslie WD Letter to the Editor from Watts and William: Comparisons between different
anti-osteoporosis medications on postfracture mortality: a population-based
study.
J Clin Endocrinol Metab. 2023 Jun 2:dgad317. doi: 10.1210. PubMed
May 2023
GRANILD-JENSEN JB, Moller-Madsen B, Rackauskaite G, Farholt S, et al Zoledronate increases bone mineral density in non-ambulant children with cerebral
palsy: A randomized, controlled trial.
J Clin Endocrinol Metab. 2023 May 26:dgad299. doi: 10.1210. PubMedAbstract available
CARBONE L, Buzkova P, Fink HA, Robbins JA, et al Plasma Levels of Branched Chain Amino Acids, Incident Hip Fractures and Bone
Mineral Density of the Hip and Spine.
J Clin Endocrinol Metab. 2023 May 18:dgad275. doi: 10.1210. PubMedAbstract available
SKJODT MK, Abrahamsen B New insights in the pathophysiology, epidemiology and response to treatment of
osteoporotic vertebral fractures.
J Clin Endocrinol Metab. 2023 May 15:dgad256. doi: 10.1210. PubMedAbstract available
HO-LE TP, Tran TS, Nguyen HG, Center JR, et al Genetic prediction of lifetime risk of fracture.
J Clin Endocrinol Metab. 2023 May 11:dgad254. doi: 10.1210. PubMedAbstract available
MEIER C, Eastell R, Pierroz DD, Lane NE, et al Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative
Review by the IOF and the ECTS.
J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210. PubMedAbstract available
MEIER C, Eastell R, Pierroz DD, Lane NE, et al Biochemical Markers of Bone Fragility in Patients With Diabetes.
J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210. PubMedAbstract available
April 2023
PACCOU J, Badr S, Lombardo D, Khizindar H, et al Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women: The ADIMOS
Case-Control Study.
J Clin Endocrinol Metab. 2023 Apr 5:dgad195. doi: 10.1210. PubMedAbstract available
March 2023
FAN W, Leder BZ, Bolster MB Response to Letter to the Editor from Riahi and Gruntmanis: 'Inpatient Zoledronic
Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis
Treatment Rates'.
J Clin Endocrinol Metab. 2023 Mar 22:dgad161. doi: 10.1210. PubMed
RIAHI S, Gruntmanis U "Letter to the Editor from Riahi and Gruntmanis: 'Inpatient Zoledronic Acid and
Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis
Treatment Rates'.
J Clin Endocrinol Metab. 2023 Mar 22:dgad162. doi: 10.1210. PubMed